CLINICAL_TRIALS
trial_result
· 2021-07-06
Clinical Trial Update: A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension [Phase 2]
Summary
Phase 2 trial evaluating efficacy and safety of LCI699 in essential hypertension has completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Essential Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2021-07-06